Varian to launch BrachyVision Acuros

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Varian Medical Systems will introduce BrachyVision Acuros, a system that allows clinicians to calculate patient doses for brachytherapy treatments, at the GEC-ESTRO exhibition in Porto, Portgual, on May 14-16.

Acuros, developed by Transpire, is a radiotherapy-specific rewrite of the software product Attila, and Varian is working with Transpire to bring the benefits of this calculation method to the radiation oncology field, according to the Palo Alto, Calif.-based company.

BrachyVision Acuros uses a technique called a Grid-Based Boltzmann Solver (GBBS), which has been added to Varian's latest brachytherapy treatment planning software offering, BrachyVision 8.8. The full system will be demonstrated for the first time at GEC-ESTRO.  

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.